Latest Breaking News On - Eric weisblum - Page 1 : comparemela.com

Silo Pharma Announces Positive Results from Study for

The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent relapse in patients with.

Eric weisblumSilo pharma incColumbia universityUniversity of marylandNew drug applicationPrivate securities litigation reform actSilo pharma

Silo Pharma (SILO) to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine

Silo Pharma (SILO) to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric weisblumSilo pharma incUdall foundationDrug administrationUniversity of marylandColumbia universitySilo pharmaReagan udall foundationCurrent useEmerging areasTherapeutic interest

Silo Pharma Announces Positive Results for Intranasal PTSD Treatment

Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric weisblumColumbia universitySilo pharma incUniversity of marylandIntranasal deliveryInvestigational new drugPrivate securities litigation reform actSilo pharma

InvestorNewsBreaks – Silo Pharma Inc (NASDAQ: SILO) Shares Positive Results for PTSD Treatment

InvestorNewsBreaks – Silo Pharma Inc (NASDAQ: SILO) Shares Positive Results for PTSD Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric weisblumLos angelesSilo pharma incColumbia universityUniversity of marylandSilo pharmaDynamic brand portfolio

Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer s Disease Therapeutic

Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer s Disease Therapeutic
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric weisblumUniversity of marylandSilo pharma incColumbia universitySilo pharmaPrivate securities litigation reform actGlobal alzheimerDisease therapeutics market